Standpoint Research Downgrades ANI Pharmaceuticals (ANIP) to Hold
Tweet
Share
E-mailGet Alerts ANIP Hot Sheet
Price: $74.77 -0.45%
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Standpoint Research downgraded ANI Pharmaceuticals (NASDAQ: ANIP) from Buy to Hold.
For an analyst ratings summary and ratings history on ANI Pharmaceuticals click here. For more ratings news on ANI Pharmaceuticals click here.
Shares of ANI Pharmaceuticals closed at $49.20 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ANI Pharmaceuticals (ANIP) PT Lowered to $119 at Guggenheim
- Wolfe Research Downgrades Stryker (SYK) to Peerperform
- Deutsche Bank Downgrades Qifu Technology (3660:HK) (QFIN) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Standpoint ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
